Treatment

KK8123 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
This study is testing a new medicine, KK8123, for adults with X-linked Hypophosphatemia (XLH). It's the first time this medicine is being given to people, to check its safety, how much to give, and how it works in the body.
For: X-linked Hypophosphatemia
United States · France · Germany